View in EDS HTML Full Text PDF Full Text

First-line durvalumab therapy alone or in combination with tremelimumab for metastatic head and neck squamous cell carcinoma: A cost-effectiveness analysis.

Saved in:
Bibliographic Details
Title: First-line durvalumab therapy alone or in combination with tremelimumab for metastatic head and neck squamous cell carcinoma: A cost-effectiveness analysis.
Authors: Li, Huijuan1,2,3 (AUTHOR), Liang, Xueyan2 (AUTHOR), Qin, Shiran3 (AUTHOR), Chen, Xiaoyu2,3 (AUTHOR), Huang, Liju2 (AUTHOR) 395154496@qq.com, Li, Yan3 (AUTHOR) yli@gxams.org.cn
Source: PLoS ONE. 5/16/2025, Vol. 20 Issue 5, p1-12. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 185233687
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: First-line durvalumab therapy alone or in combination with tremelimumab for metastatic head and neck squamous cell carcinoma: A cost-effectiveness analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Li%2C+Huijuan%22">Li, Huijuan</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liang%2C+Xueyan%22">Liang, Xueyan</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Qin%2C+Shiran%22">Qin, Shiran</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+Xiaoyu%22">Chen, Xiaoyu</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huang%2C+Liju%22">Huang, Liju</searchLink><relatesTo>2</relatesTo> (AUTHOR)<i> 395154496@qq.com</i><br /><searchLink fieldCode="AR" term="%22Li%2C+Yan%22">Li, Yan</searchLink><relatesTo>3</relatesTo> (AUTHOR)<i> yli@gxams.org.cn</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22PLoS+ONE%22">PLoS ONE</searchLink>. 5/16/2025, Vol. 20 Issue 5, p1-12. 12p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=185233687
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.pone.0324057
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 12
        StartPage: 1
    Titles:
      – TitleFull: First-line durvalumab therapy alone or in combination with tremelimumab for metastatic head and neck squamous cell carcinoma: A cost-effectiveness analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Li, Huijuan
      – PersonEntity:
          Name:
            NameFull: Liang, Xueyan
      – PersonEntity:
          Name:
            NameFull: Qin, Shiran
      – PersonEntity:
          Name:
            NameFull: Chen, Xiaoyu
      – PersonEntity:
          Name:
            NameFull: Huang, Liju
      – PersonEntity:
          Name:
            NameFull: Li, Yan
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 05
              Text: 5/16/2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 19326203
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: PLoS ONE
              Type: main
ResultId 1